Pairing knowledge and analysis experience to revolutionize the invention, improvement and commercialization of life sciences improvements
Cerner Corporation as we speak introduced the acquisition of Kantar Well being, a division of Kantar Group, for $375 million in money, topic to adjustment. Kantar Well being’s wealthy life sciences experience might be mixed with Cerner’s sturdy assortment of real-world knowledge (RWD) and expertise and is anticipated to speed up innovation in life sciences analysis and enhance affected person outcomes worldwide.
“The promise of real-world proof to energy drug discovery is true in entrance of us,” stated Donald Trigg, president, Cerner. “Kantar Well being is a crucial subsequent step in constructing out the capabilities our rising community of supplier shoppers have to essentially change the time and value for medical trials.”
The extremely skilled groups at Kantar Well being carry deep understanding of the wants of the pharmaceutical and life sciences trade. Their analysis and consulting options, complemented by Cerner’s RWD, place Cerner to assist life sciences corporations and analysis organizations with all points of the therapeutic lifecycle.
The rising Cerner Learning Health NetworkSM shopper consortium, which as we speak represents 92 million sufferers and 776 million medical encounters, will be capable to interact extra with life sciences corporations for funded analysis research. A stronger collaboration between suppliers and the pharmaceutical trade is enabled by way of this acquisition. It’s going to assist researchers generate extra well being insights and use differentiated RWD belongings and experience to deal with probably the most advanced medical analysis questions.
Because of the transaction closing, the Kantar Well being group positioned world wide is becoming a member of Cerner and might be built-in inside its Strategic Development enterprise. This consists of Kantar Well being’s analysis and consulting options and international shoppers. Lynnette Cooke, head of Kantar Well being, will proceed to steer the group and be part of the Cerner management.
“Kantar Well being and Cerner’s Strategic Development enterprise have an important deal in widespread, beginning with a imaginative and prescient to advance affected person care world wide. Culturally, we share the identical values in the case of how we develop our individuals, our provide and our shopper base. I’m excited to proceed main the group as we combine with Cerner,” stated Cooke. “I’ve nice admiration for Cerner’s well being applied sciences and am impressed by their strategic imaginative and prescient for future development. Our collective capabilities and belongings will allow the acceleration of innovation and elevate our experience in addressing probably the most advanced medical analysis questions altering the way in which healthcare is developed and delivered.”
All statements on this press launch that don’t immediately and completely relate to historic information represent forward-looking statements. These forward-looking statements are based mostly on the present beliefs, expectations and assumptions of Cerner’s administration with respect to future occasions and are topic to various important dangers and uncertainties. It is very important notice that Cerner’s efficiency, and precise outcomes, monetary situation or enterprise might differ materially from these expressed in such forward-looking statements. The phrases “anticipated” and “place”, or the unfavourable of those phrases, variations thereof or related expressions are supposed to establish such forward-looking statements. For instance, our forward-looking statements embrace statements relating to the longer term advantages or synergies of the transaction. Components that would trigger or contribute to such variations embrace, however aren’t restricted to: dangers inherent with enterprise acquisitions and integrations, akin to difficulties and operational and monetary dangers related to integrating Cerner and the acquired enterprise usually and through the COVID-19 pandemic; the incidence of any occasion, change or different circumstances that would make closing in a selected nation impracticable; dangers associated to disruption of administration time from ongoing enterprise operations as a result of transaction and integration; failure to appreciate the synergies, market alternatives and different advantages anticipated from the transaction; threat that the belongings and enterprise acquired could not proceed to be commercially profitable; the power of Cerner and Kantar Well being to retain clients and key personnel and to keep up relationships with key suppliers of the acquired enterprise; surprising prices, expenses or bills ensuing from the transaction or the combination; litigation or claims regarding the transaction or the acquired belongings and enterprise; and the extent to which the COVID-19 pandemic and measures taken in response thereto might adversely have an effect on the enterprise acquired and the assumptions administration has utilized in its analysis of the transaction. Further dialogue of those and different dangers, uncertainties and elements affecting Cerner’s enterprise is contained in Cerner’s filings with the Securities and Change Fee. The reader shouldn’t place undue reliance on forward-looking statements, because the statements converse solely as of the date that they’re made. Besides as required by regulation, Cerner undertakes no obligation to replace or revise forward-looking statements to mirror modified assumptions, the incidence of unanticipated occasions, or adjustments in our enterprise, outcomes of operations or monetary situation over time.